Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea

Inclusion Criteria

• •1. Patients initially diagnosed as locally advanced pancreatic cancer or metastatic pancreatic cancer and received chemotherapy between 2012 and 2021
• •2. Histologically or cytologically confirmed adenocarcinoma of exocrine pancreas
• •3. Documented metastatic disease; disease status may be measurable or non-measurable as defined by RECIST v1.1 guidelines
• •4. Locally advanced pancreatic cancer; disease status was defined by NCCN guidelines.
• •5. Recovered from the effects of any prior surgery, radiotherapy, or other antineoplastic therapy
• •6. At least 18 years of age